{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:17:09Z","timestamp":1776338229329,"version":"3.51.2"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.intimp.2021.107617","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T07:21:36Z","timestamp":1618816896000},"page":"107617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Association of CTLA-4 (+49 A\/G) polymorphism with susceptibility to autoimmune diseases: A meta-analysis with trial sequential analysis"],"prefix":"10.1016","volume":"96","author":[{"given":"Lingxiang","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feier","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangping","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongwen","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faming","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107617_b0005","article-title":"An updated advance of autoantibodies in autoimmune diseases","author":"Xiao","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2021.107617_b0010","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1172\/JCI97965","article-title":"Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation","volume":"128","author":"Zou","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2021.107617_b0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/cmi.2016.60","article-title":"uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K\/Akt signaling pathway in patients with rheumatoid arthritis","volume":"15","author":"Liu","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2021.107617_b0020","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2105\/AJPH.90.9.1463","article-title":"Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States","volume":"90","author":"Walsh","year":"2000","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.intimp.2021.107617_b0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.autrev.2019.03.013","article-title":"Influence of HLA-DRB1 susceptibility alleles on the autoantibodies spectrum of systemic lupus erythematosus in European part of Russia","volume":"18","author":"Tkachenko","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2021.107617_b0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.it.2008.06.005","article-title":"Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other","volume":"29","author":"Horwitz","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2021.107617_b0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and maintenance of regulatory T cells","volume":"38","author":"Ohkura","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2021.107617_b0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/328267a0","article-title":"A new member of the immunoglobulin superfamily\u2013CTLA-4","volume":"328","author":"Brunet","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.107617_b0045","doi-asserted-by":"crossref","first-page":"9296","DOI":"10.1073\/pnas.94.17.9296","article-title":"Thymocyte development is normal in CTLA-4-deficient mice","volume":"94","author":"Chambers","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2021.107617_b0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0952-7915(98)80170-2","article-title":"Negative regulation of T cell activation","volume":"10","author":"Saito","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2021.107617_b0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","article-title":"CTLA-4 can function as a negative regulator of T cell activation","volume":"1","author":"Walunas","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2021.107617_b0060","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","volume":"30","author":"Ohkura","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2021.107617_b0065","first-page":"39","article-title":"Expression and functional significance of CTLA-4, a negative regulator of T cell activation","volume":"49","author":"Kosmaczewska","year":"2001","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.intimp.2021.107617_b0070","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.4049\/jimmunol.151.7.3489","article-title":"Characterization of CTLA-4 structure and expression on human T cells","volume":"151","author":"Lindsten","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.107617_b0075","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.176.6.1595","article-title":"Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes","volume":"176","author":"Linsley","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2021.107617_b0080","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.156.11.4154","article-title":"Regulation of CTLA-4 expression during T cell activation","volume":"156","author":"Perkins","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.107617_b0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/gtmb.2016.0335","article-title":"CTLA-4 +49 G\/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis","volume":"21","author":"Wang","year":"2017","journal-title":"Genet. Test Mol. Biomarkers"},{"key":"10.1016\/j.intimp.2021.107617_b0090","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s11033-012-2349-6","article-title":"Association of the CTLA-4 +49A\/G polymorphism with rheumatoid arthritis in Chinese Han population","volume":"40","author":"Tang","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.intimp.2021.107617_b0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.gene.2012.12.030","article-title":"Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis","volume":"516","author":"Chen","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2021.107617_b0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00296-013-2894-x","article-title":"Associations of the PTPN22 and CTLA-4 genetic polymorphisms with Taiwanese ankylosing spondylitis","volume":"34","author":"Huang","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.intimp.2021.107617_b0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1399-0039.2009.01411.x","article-title":"Polymorphisms of cytotoxic T lymphocyte-associated antigen-4 and cytokine genes in Taiwanese patients with ankylosing spondylitis","volume":"75","author":"Lee","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.intimp.2021.107617_b0110","first-page":"7421","article-title":"Association between CTLA-4 gene polymorphism and ankylosing spondylitis: a case-control study","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Patho."},{"key":"10.1016\/j.intimp.2021.107617_b0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10875-009-9356-y","article-title":"Association of CTLA4 Gene Polymorphism in Iranian Patients with Ankylosing Spondylitis","volume":"30","author":"Azizi","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.intimp.2021.107617_b0120","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/crj.12388","article-title":"Relationship of CTLA4 and CD28 polymorphisms with lung involvement, HRCT findings and pulmonary function tests in Turkish patients with ankylosing spondylitis","volume":"11","author":"Karakose Okyalt\u0131r\u0131k","year":"2015","journal-title":"Clin. Respirat. J."},{"key":"10.1016\/j.intimp.2021.107617_b0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10067-003-0720-7","article-title":"Association of CTLA4 gene A-G polymorphism with rheumatoid arthritis in Chinese","volume":"22","author":"Lee","year":"2003","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2021.107617_b0130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.ejhg.5201423","article-title":"Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population","volume":"13","author":"Lei","year":"2005","journal-title":"Eur. J. Hum. Genet.: EJHG"},{"key":"10.1016\/j.intimp.2021.107617_b0135","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.4238\/2013.April.25.8","article-title":"CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China","volume":"12","author":"Liu","year":"2013","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.intimp.2021.107617_b0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10067-003-0776-4","article-title":"CTLA-4 gene polymorphism in promoter and exon-1 regions is not associated with Chinese patients with rheumatoid arthritis","volume":"23","author":"Liu","year":"2004","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2021.107617_b0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/rheumatology\/41.2.180","article-title":"An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies","volume":"41","author":"Vaidya","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2021.107617_b0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.yexmp.2005.09.004","article-title":"The CTLA4 + 49A\/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland","volume":"80","author":"Suppiah","year":"2006","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.intimp.2021.107617_b0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/rheumatology\/39.1.63","article-title":"A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis","volume":"39","author":"Barton","year":"2000","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.intimp.2021.107617_b0160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1034\/j.1399-0039.2001.580110.x","article-title":"Polymorphism in codon 17 of the CTLA-4 gene (+49 A\/G) is not associated with susceptibility to rheumatoid arthritis in British Caucasians","volume":"58","author":"Milicic","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.intimp.2021.107617_b0165","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cca.2010.02.001","article-title":"The +49A>G CTLA-4 polymorphism is associated with rheumatoid arthritis in Mexican population","volume":"411","author":"Mu\u00f1oz-Valle","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2021.107617_b0170","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1034\/j.1399-0039.1999.530311.x","article-title":"CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis","volume":"53","author":"Gonzalez Escribano","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.intimp.2021.107617_b0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gene.2014.12.046","article-title":"Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) +49 A>G gene polymorphism in Egyptian cases with rheumatoid arthritis","volume":"558","author":"Elshazli","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2021.107617_b0180","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s10067-016-3496-2","article-title":"CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis","volume":"36","author":"Luterek-Puszy\u0144ska","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2021.107617_b0185","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.2007.079186","article-title":"CTLA-4 CT60 polymorphism is not an independent genetic risk marker of rheumatoid arthritis in a Japanese population","volume":"67","author":"Tsukahara","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2021.107617_b0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0039.1998.tb02947.x","article-title":"CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis","volume":"51","author":"Seidl","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.intimp.2021.107617_b0195","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/rheumatology\/40.12.1370","article-title":"HLA-DQB1 CAR1\/CAR2, TNFa IR2\/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjogren's syndrome","volume":"40","author":"Hadj","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2021.107617_b0200","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/030097402760375142","article-title":"No association of polymorphisms of the CTLA-4 exon 1(+49) and promoter(-318) genes with rheumatoid arthritis in the Korean population","volume":"31","author":"Lee","year":"2002","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.intimp.2021.107617_b0205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/03009740500407651","article-title":"The genetic contribution of CTLA-4 dimorphisms in promoter and exon 1 regions in Japanese patients with rheumatoid arthritis","volume":"35","author":"Takeuchi","year":"2006","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.intimp.2021.107617_b0210","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/art.24412","article-title":"CTLA4\/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population","volume":"60","author":"Walker","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2021.107617_b0215","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.20118","article-title":"Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis","volume":"50","author":"Barton","year":"2004","journal-title":"Arthritis Rheumatism."},{"key":"10.1016\/j.intimp.2021.107617_b0220","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s10067-011-1752-z","article-title":"CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and Hashimoto thyroiditis-results and the review of the literature","volume":"30","author":"Benhatchi","year":"2011","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2021.107617_b0225","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijheh.2011.10.010","article-title":"Genetic polymorphisms and surface expression of CTLA-4 and PD-1 on T cells of silica-exposed workers","volume":"215","author":"Rocha","year":"2011","journal-title":"Int. J. Hyg. Envir. Heal."},{"key":"10.1016\/j.intimp.2021.107617_b0230","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1089\/gtmb.2012.0391","article-title":"Overexpression and Secretion of the SolubleCTLA-4 Splice Variant in Various Autoimmune Diseases and in Cases with Overlapping Autoimmunity","volume":"17","author":"AlFadhli","year":"2013","journal-title":"Genet. Test. Mol. Bioma."},{"key":"10.1016\/j.intimp.2021.107617_b0235","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1034\/j.1399-0039.1999.540607.x","article-title":"Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method","volume":"54","author":"Matsushita","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.intimp.2021.107617_b0240","first-page":"229","article-title":"Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population","volume":"29","author":"Kimkong","year":"2011","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.intimp.2021.107617_b0245","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1191\/096120301682430249","article-title":"CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus","volume":"10","author":"Liu","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2021.107617_b0250","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1744-313X.2009.00856.x","article-title":"CTLA-4 gene polymorphism of exon 1(+49 A\/G) in Turkish systemic lupus erythematosus patients","volume":"36","author":"Ulker","year":"2009","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.intimp.2021.107617_b0255","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00439-002-0807-2","article-title":"CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region","volume":"111","author":"Hudson","year":"2002","journal-title":"Hum. Genet."},{"key":"10.1016\/j.intimp.2021.107617_b0260","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0198-8859(03)00171-X","article-title":"CTLA4 polymorphism in spanish patients with systemic lupus erythematosus","volume":"64","author":"Aguilar","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.intimp.2021.107617_b0265","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1191\/096120301682430177","article-title":"Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus","volume":"10","author":"Lee","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2021.107617_b0270","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/03014460903325185","article-title":"Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia","volume":"37","author":"Chua","year":"2010","journal-title":"Ann. Hum. Biol."},{"key":"10.1016\/j.intimp.2021.107617_b0275","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ard.58.3.193","article-title":"The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus","volume":"58","author":"Heward","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2021.107617_b0280","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/1529-0131(200001)43:1<120::AID-ANR15>3.0.CO;2-3","article-title":"Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10","volume":"43","author":"D'Alfonso","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2021.107617_b0285","first-page":"527","article-title":"CTLA-4 dimorphisms in Japanese patients with systemic lupus erythematosus","volume":"21","author":"Takeuchi","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2021.107617_b0290","first-page":"399","article-title":"Study on the correlation between CTLA-4 gene polymorphism and systemic lupus erythematosus","author":"Peng","year":"2001","journal-title":"Immunol. J."},{"key":"10.1016\/j.intimp.2021.107617_b0295","first-page":"439","article-title":"Study on the correlation between CTLA-4 gene polymorphism and systemic lupus erythematosus","volume":"31","author":"Yu","year":"2010","journal-title":"Med. J. Wuhan Univ."},{"key":"10.1016\/j.intimp.2021.107617_b0300","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/rheumatology\/40.6.662","article-title":"Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population","volume":"40","author":"Ahmed","year":"2001","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.intimp.2021.107617_b0305","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.humimm.2015.11.002","article-title":"Association of CTLA4 exon-1 polymorphism with the tumor necrosis factor-alpha in the risk of systemic lupus erythematosus among South Indians","volume":"77","author":"Katkam","year":"2015","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.intimp.2021.107617_b0310","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.ejhg.5201214","article-title":"Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus","volume":"12","author":"Barreto","year":"2004","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"10.1016\/j.intimp.2021.107617_b0315","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/tan.12363","article-title":"The CTLA4 +49 A\/G (rs231775) polymorphism influences susceptibility to SLE in South Indian Tamils","volume":"83","author":"Devaraju","year":"2014","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.intimp.2021.107617_b0320","first-page":"725","article-title":"Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus","volume":"17","author":"Pullmann","year":"1999","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2021.107617_b0325","first-page":"47","article-title":"Correlation between exon I A\/G~(49) polymorphism of CTLA-4 gene and systemic lupus erythematosus in Yunnan Han nationality","author":"Jin","year":"2009","journal-title":"Kunming Med. College"},{"key":"10.1016\/j.intimp.2021.107617_b0330","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1740774507081219","article-title":"Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes","volume":"4","author":"Hu","year":"2007","journal-title":"Clin. Trials."},{"key":"10.1016\/j.intimp.2021.107617_b0335","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jclinepi.2008.08.010","article-title":"Updating meta-analyses leads to larger type I errors than publication bias","volume":"62","author":"Borm","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.intimp.2021.107617_b0340","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0197-2456(96)00014-1","article-title":"Uncertainty of the time of first significance in random effects cumulative meta-analysis","volume":"17","author":"Berkey","year":"1996","journal-title":"Control Clin Trials."},{"key":"10.1016\/j.intimp.2021.107617_b0345","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/08916934.2016.1261833","article-title":"Interleukin-6-174G > C (rs1800795) polymorphism distribution and its association with rheumatoid arthritis: A case-control study and meta-analysis","volume":"50","author":"Dar","year":"2017","journal-title":"Autoimmunity."},{"key":"10.1016\/j.intimp.2021.107617_b0350","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Med. Res. Method."},{"key":"10.1016\/j.intimp.2021.107617_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106221","article-title":"CTLA-4: From mechanism to autoimmune therapy","volume":"80","author":"Hosseini","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.107617_b0360","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13317-010-0011-7","article-title":"The soluble CTLA-4 receptor and its role in autoimmune diseases: an update","volume":"1","author":"Saverino","year":"2010","journal-title":"Auto Immun. Highlights"},{"key":"10.1016\/j.intimp.2021.107617_b0365","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/1756-185X.12705","article-title":"The association between CTLA-4 (+49 A\/G) polymorphism and susceptibility to ankylosing spondylitis: a meta-analysis","volume":"19","author":"Wu","year":"2016","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.intimp.2021.107617_b0370","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s10875-012-9650-y","article-title":"Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis","volume":"32","author":"Li","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.intimp.2021.107617_b0375","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13000-014-0157-0","article-title":"The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis","volume":"9","author":"Li","year":"2014","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.intimp.2021.107617_b0380","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1007\/s11033-011-1364-3","article-title":"Association between the CTLA-4 +49 A\/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis","volume":"39","author":"Lee","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.intimp.2021.107617_b0385","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1007\/s11033-012-2125-7","article-title":"CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis","volume":"40","author":"Zhai","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.intimp.2021.107617_b0390","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00296-013-2894-x","article-title":"Associations of the PTPN22 and CTLA-4 genetic polymorphisms with Taiwanese ankylosing spondylitis","volume":"34","author":"Huang","year":"2014","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.intimp.2021.107617_b0395","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/gtmb.2012.0302","article-title":"CTLA-4 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis","volume":"17","author":"Liu","year":"2013","journal-title":"Genet. Test Mol. Biomarkers"},{"key":"10.1016\/j.intimp.2021.107617_b0400","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00439-004-1244-1","article-title":"CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis","volume":"116","author":"Lee","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.intimp.2021.107617_b0405","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2021.107617_b0410","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ng.3434","article-title":"Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus","volume":"47","author":"Bentham","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2021.107617_b0415","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.107617_b0420","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/1076029617733040","article-title":"Phenotyping of CYP 4501A2 Activity by Total Overnight Salivary Caffeine Assessment (TOSCA) in Patients on Warfarin Treatment: A Cross-Sectional Study","volume":"24","author":"Tarantino","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921002538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921002538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T18:54:10Z","timestamp":1727290450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921002538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":84,"alternative-id":["S1567576921002538"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107617","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of CTLA-4 (+49 A\/G) polymorphism with susceptibility to autoimmune diseases: A meta-analysis with trial sequential analysis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107617"}}